0.00Open0.00Pre Close0 Volume0 Open Interest17.50Strike Price0.00Turnover94.12%IV-42.97%PremiumOct 18, 2024Expiry Date5.26Intrinsic Value100Multiplier20DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9412Delta0.0518Gamma2.31Leverage Ratio-0.0064Theta-0.0048Rho-2.17Eff Leverage0.0033Vega
Stoke Therapeutics Stock Discussion
In the rapidly evolving world of biotechnology, companies like Stoke Therapeutics are pioneering groundbreaking treatments that could potentially change the lives of patients with severe diseases. The recent buzz surrounding Stoke Therapeutics, particularly their work on an anti-epilepsy drug, STK-001, underscores the transformative potential of RNA-based therapies in addres...
No comment yet